Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What are the main considerations when prescribing pharmacotherapy for Parkinson’s disease?
Thomas Müller
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 7, pp. 745-750
Open Access | Times Cited: 10

Showing 10 citing articles:

Aminoadamantanes: from treatment of Parkinson’s and Alzheimer’s disease to symptom amelioration of long COVID-19 syndrome?
Thomas Müller, Peter Riederer, W. Kuhn
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 2, pp. 101-107
Closed Access | Times Cited: 14
The role of istradefylline in the Parkinson’s disease armamentarium
Thomas Müller
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 7, pp. 863-871
Closed Access | Times Cited: 11
DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson’s disease
Thomas Müller
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 787-792
Closed Access | Times Cited: 6
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson’s disease
Thomas Müller, Peter Riederer
Journal of Neural Transmission (2023) Vol. 131, Iss. 6, pp. 631-638
Closed Access | Times Cited: 4
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations
Onanong Phokaewvarangkul, Roongroj Bhidayasiri, Pedro Ruiz, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1451-1462
Closed Access | Times Cited: 4
The Wahls Behavior Change Model for Complex Chronic Diseases: A Clinician’s Guide
Alaina N Elliott-Wherry, Jennifer E. Lee, Amy Pearlman, et al.
Degenerative Neurological and Neuromuscular Disease (2022) Vol. Volume 12, pp. 111-125
Open Access | Times Cited: 5
Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease
Thomas Müller, Carsten Buhmann, Martin Delf, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1455-1462
Closed Access
Therapeutic drug monitoring in Parkinson’s disease
Thomas Müller, Manfred Gerlach, Gudrun Hefner, et al.
Journal of Neural Transmission (2024)
Closed Access
Perspective: cell death mechanisms and early diagnosis as precondition for disease modification in Parkinson’s disease: are we on the right track?
Thomas Müller
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 4, pp. 403-409
Closed Access | Times Cited: 1
Perspective: Is a Closer Interaction between Experimental and Clinical Research Paradigms in Chronic Neurodegeneration, Such as Parkinson’s Disease, Necessary Again?
Thomas Müller
Cells (2022) Vol. 12, Iss. 1, pp. 157-157
Open Access | Times Cited: 1
Page 1

Scroll to top